成人T细胞白血病/淋巴瘤整合遗传谱的预后相关性
研究基于414例和463例成人T细胞白血病/淋巴瘤(ATL)患者的靶向捕获测序和单核苷酸多态性阵列核型分析数据,探讨常见遗传改变对疾病表型和临床结局的影响。侵袭性亚型遗传与表观遗传改变负荷更高,TP53和IRF4突变及PD-L1扩增、CDKN2A缺失等拷贝数改变更多;STAT3突变在惰性ATL中更常见。体细胞突变和拷贝数改变数量越高,生存越差。
要点
- 侵袭性ATL亚型遗传与表观遗传改变负荷更高,TP53和IRF4突变及PD-L1扩增、CDKN2A缺失等拷贝数改变更多。
- STAT3突变在惰性ATL中更常见;体细胞突变和拷贝数改变数量越高,生存越差。
- PD-L1扩增是侵袭性和惰性ATL中均强的遗传预后预测因子。
核心结论
- ATL亚型可进一步分为分子特征不同、预后不同的亚群,遗传谱分析可能有助于改善ATL患者的预后判断和管理。
研究设计与样本
- 基于414例和463例ATL患者的靶向捕获测序和单核苷酸多态性阵列核型分析数据,研究常见遗传改变对疾病表型和临床结局的影响。
主要发现
- 侵袭性(急性/淋巴瘤)亚型与惰性(慢性/冒烟)亚型相比,遗传和表观遗传改变负荷增加,TP53和IRF4突变频率更高,PD-L1扩增和CDKN2A缺失等拷贝数改变更多。
- STAT3突变在惰性ATL中更常见。
- 体细胞突变和拷贝数改变数量越高,生存越差。
- 在侵袭性ATL的多因素分析中,日本临床肿瘤学组预后指数高风险、年龄较大、PRKCB突变和PD-L1扩增是独立的不良预后因素。
- 在惰性ATL中,IRF4突变、PD-L1扩增和CDKN2A缺失与较短生存显著相关,但具有不良临床因素的慢性亚型仅边缘显著。
关键数值与推荐
- 侵袭性ATL的多因素分析中,日本临床肿瘤学组预后指数高风险、年龄较大、PRKCB突变和PD-L1扩增为独立不良预后因素。
- 惰性ATL中,IRF4突变、PD-L1扩增和CDKN2A缺失与较短生存显著相关,慢性亚型伴不良临床因素仅边缘显著。
- PD-L1扩增是侵袭性和惰性ATL中均强的遗传预测因子。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult T-cell leukemia/lymphoma (ATL) is a heterogeneous group of peripheral T-cell malignancies characterized by human T-cell leukemia virus type-1 infection, whose genetic profile has recently been fully investigated. However, it is still poorly understood how these alterations affect clinical features and prognosis. We investigated the effects of genetic alterations commonly found in ATL on disease phenotypes and clinical outcomes, based on genotyping data obtained from 414 and 463 ATL patients using targeted-capture sequencing and single nucleotide polymorphism array karyotyping, respectively. Aggressive (acute/lymphoma) subtypes were associated with an increased burden of genetic and epigenetic alterations, higher frequencies of TP53 and IRF4 mutations, and many copy number alterations (CNAs), including PD-L1 amplifications and CDKN2A deletions, compared with indolent (chronic/smoldering) subtypes. By contrast, STAT3 mutations were more characteristic of indolent ATL. Higher numbers of somatic mutations and CNAs significantly correlated with worse survival. In a multivariate analysis incorporating both clinical factors and genetic alterations, the Japan Clinical Oncology Group prognostic index high-risk, older age, PRKCB mutations, and PD-L1 amplifications were independent poor prognostic factors in aggressive ATL. In indolent ATL, IRF4 mutations, PD-L1 amplifications, and CDKN2A deletions were significantly associated with shorter survival, although the chronic subtype with unfavorable clinical factors was only marginally significant. Thus, somatic alterations characterizing aggressive diseases predict worse prognosis in indolent ATL, among which PD-L1 amplifications are a strong genetic predictor in both aggressive and indolent ATL. ATL subtypes are further classified into molecularly distinct subsets with different prognosis. Genetic profiling might contribute to improved prognostication and management of ATL patients.
引用
- Kataoka K, Iwanaga M, Yasunaga JI, et al. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. Blood. 2017. PMID: 29084771. doi:10.1182/blood-2017-01-761874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。